New Clues to How Cancer Patients’ Genes Influence Treatment
It absorbed nearly 50% of potentially damaging rays, but more study is needed, researchers say Source: General Cancer News Articles Provided by Cancer Compass
It absorbed nearly 50% of potentially damaging rays, but more study is needed, researchers say Source: General Cancer News Articles Provided by Cancer Compass
Half of breast cancer patients stop taking key medications ahead of schedule, a decision that can increase their risk of relapse and death, a new study shows. Source: General Cancer News Articles Provided by Cancer Compass
Biodesix, Inc., a company developing and commercializing molecular diagnostics for personalized medicine, announced that the United States Patent and Trademark Office has awarded to the Company patent number 7,736,905. The patent provides coverage for the Company’s first product, VeriStrat, which is used by physicians to help guide therapy [...]
Groundbreaking studies will be presented at the ESMO 12th World Congress on Gastrointestinal Cancer next week in Barcelona, Spain, including exciting new data on treatment for neuroendocrine tumors. Source: General Cancer News Articles Provided by Cancer Compass
Active surveillance or watchful waiting might be sufficient treatment for patients with prostate cancer that has a low risk of progression, according to a new study published online June 18 in The Journal of the National Cancer Institute. Source: General Cancer News Articles Provided by Cancer Compass
A new study led by UNC researchers that looks at newly diagnosed lung cancer patients and follows them from diagnosis forward is one of the first to give reasons why patients don’t go to lung surgery and why surgery happens less often in blacks. Source: General Cancer News Articles Provided by [...]
The first discovery of a cancer gene marker–the BRAF oncogene for melanoma and colorectal malignancies–back in 2002 changed the way many researchers thought about cancer treatment. Rather than approach the disease based on what region of the body it stemmed from, scientists began to identify cancers in terms of their genetic signatures. Researchers [...]
Cyclosporine treatment develops higher de novo cancer risk in liver transplant patients: Researchers Researchers at Erasmus MC University Medical Centre in The Netherlands found that cyclosporine treatment is a significant risk factor for the development of de novo cancer in liver transplant patients. Full details appear in the July issue of Liver Transplantation, a journal published [...]
Causes Of Survival Disparities Based On Insurance Among Rectal Cancer Patients: Study Disparities in cancer stage and treatment are the main reasons why Medicaid-insured and uninsured rectal cancer patients are twice as likely to die within five years as privately insured patients. That is the conclusion of a new study published early online in Cancer, a [...]
Study examines reasons patients with early stage lung cancer do not have surgery Despite a greater likelihood of poorer outcomes, many patients newly-diagnosed with early-stage lung cancer do not undergo surgery. New research indicates that among the factors associated with this decision include misunderstandings of the prognosis, negative perceptions of patient-physician communication and older age, with [...]